Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Cyclin G Polyclonal Antibody, PerCP Conjugated

Product Specifications

Background

May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation (By similarity) .

Synonyms

CCNG; Cyclin-G1; Cyclin-G; CCNG1; CYCG1

Gene ID

900

Swiss Prot

P51959

Cellular Locus

Nucleus

Host

Rabbit

Cross Reactivity

Human, Mouse

Immunogen

181-295/295

Target

Cyclin G

Clonality

Polyclonal

Isotype

IgG

Conjugation

PerCP

Source

KLH conjugated synthetic peptide derived from human Cyclin G

Applications

WB, IF (IHC-P), IF (IHC-F), IF (ICC)

Purification

Purified by Protein A.

Excitation Emission

482nm/677nm

Concentration

1µg/µl

Dilution

WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Gene ID URL

900

Predicted Cross Reactivity

Rat, Dog, Cow, Pig, Horse, Chicken, Rabbit

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

PRL Recombinant Antibody, APC Conjugated
bsm-61757R-APC 100 µL

PRL Recombinant Antibody, APC Conjugated

Ask
View Details
CD8b Antibody
E38PA2941 100 µL

CD8b Antibody

Ask
View Details
Anti-Pycard (mouse) antibody
STJ72989 100 µg

Anti-Pycard (mouse) antibody

Ask
View Details
Human GDPD2 Knockout A549 cell line
GTR15414890 1 Vial

Human GDPD2 Knockout A549 cell line

Ask
View Details
CD22, Recombinant, Human, aa20-687, hIgG-His-Tag (B-Cell Receptor CD22 Isoform 1, SIGLEC-2, SIGLEC2)
396842 10 µg

CD22, Recombinant, Human, aa20-687, hIgG-His-Tag (B-Cell Receptor CD22 Isoform 1, SIGLEC-2, SIGLEC2)

Ask
View Details